The first case of Chinese medicine extract standard entering Western Pharmacopoeia -- China should give full play to its advantages as a big country of Chinese herbal medicine resources
Recently, the API of Panax notoginseng Tongshu capsule entered the German Pharmacopoeia code of 2018. As an effective component of Panax notoginseng Tongshu capsule, "Panax notoginseng Extract" is the first Chinese medicine extract with independent intellectual property rights to enter the Pharmacopoeia of western developed countries, which represents an important achievement in the process of Chinese traditional medicine internationalization.
